FDA recall, , Moderate risk
LifeSouth Community Blood Centers Apheresis Red Blood Cells
Apheresis Red Blood Cells, Leukocytes Reduced, Irradiated were distributed without required testing.
Recall ended Aug 7, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
LifeSouth Community Blood Centers, Inc. began a recall of Apheresis Red Blood Cells, Leukocytes Reduced, Irradiated on August 4, 2025, because the cells were collected on an apheresis machine that required verification of hematocrit and red cell volume but were not tested, and were distributed. The FDA added the recall to its Enforcement Report and classified it on August 7, 2026. The product was distributed in Georgia.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Compare these details with yours, then check the recall notice to see which units are recalled.
Apheresis Red Blood Cells, Leukocytes Reduced, Irradiated
Recall details
- Company began the recall
- Sold in
- Company
- LifeSouth Community Blood Centers, Inc.
- Hazard
- Quality testing problem
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 99411
- Recall number
- B-0170-2026
All recalls from LifeSouth Community Blood Centers, Inc.
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
In FDA's weekly enforcement report
Listed on Recall Canary
